ATE377008T1 - Imidazolderivate als glutamatrezeptorantagonisten - Google Patents

Imidazolderivate als glutamatrezeptorantagonisten

Info

Publication number: ATE377008T1
Authority: AT; Austria
Prior art keywords: glutama; receptor antagonists; imidazole derivatives; imidazole; derivatives
Prior art date: 2003-06-05

Application number

AT04739484T

Other languages

English (en)

Inventor

Bernd Buettelmann

Simona Ceccarelli

Georg Jaeschke

Richard Porter

Eric Vieira

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-05

Filing date

2004-06-01

Publication date

2007-11-15

2004-06-01 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE377008T1 publication Critical patent/ATE377008T1/de

Links

RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT04739484T 2003-06-05 2004-06-01 Imidazolderivate als glutamatrezeptorantagonisten ATE377008T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03012200		2003-06-05

Publications (1)

Publication Number	Publication Date
ATE377008T1 true ATE377008T1 (de)	2007-11-15

Family

ID=33483899

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04739484T ATE377008T1 (de)	2003-06-05	2004-06-01	Imidazolderivate als glutamatrezeptorantagonisten

Country Status (38)

Country	Link
US (3)	US7332510B2 (de)
EP (1)	EP1636206B1 (de)
JP (1)	JP4401384B2 (de)
KR (1)	KR100778948B1 (de)
CN (1)	CN100408572C (de)
AR (1)	AR044478A1 (de)
AT (1)	ATE377008T1 (de)
AU (1)	AU2004245208B2 (de)
BR (1)	BRPI0411095B8 (de)
CA (1)	CA2527315C (de)
CL (1)	CL2004001347A1 (de)
CR (1)	CR8094A (de)
CY (1)	CY1107856T1 (de)
DE (1)	DE602004009796T2 (de)
DK (1)	DK1636206T3 (de)
EA (1)	EA010577B1 (de)
EC (1)	ECSP056202A (de)
ES (1)	ES2294504T3 (de)
GT (1)	GT200400117A (de)
HN (1)	HN2004000208A (de)
HR (1)	HRP20070529T3 (de)
IL (1)	IL171930A (de)
MA (1)	MA27881A1 (de)
MX (1)	MXPA05013149A (de)
MY (2)	MY137272A (de)
NO (1)	NO332143B1 (de)
NZ (1)	NZ543637A (de)
PA (1)	PA8604101A1 (de)
PE (1)	PE20050162A1 (de)
PL (1)	PL1636206T3 (de)
PT (1)	PT1636206E (de)
RS (1)	RS53183B (de)
SI (1)	SI1636206T1 (de)
TN (2)	TNSN05309A1 (de)
TW (1)	TWI338007B (de)
UA (1)	UA80888C2 (de)
WO (1)	WO2004108701A1 (de)
ZA (2)	ZA200509807B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA80888C2 (en) *	2003-06-05	2007-11-12	Hoffmann La Roche	Imidazole derivatives as glutmate receptor antagonists
US7531529B2 (en)	2003-06-05	2009-05-12	Roche Palo Alto Llc	Imidazole derivatives
US7452909B2 (en)	2003-09-04	2008-11-18	Hoffman-La Roche Inc.	Imidazole derivatives
HRP20080363T3 (hr)	2004-06-01	2008-09-30	F. Hoffmann - La Roche Ag	Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora
GB0514296D0 (en) *	2005-07-12	2005-08-17	Novartis Ag	Organic compounds
DE102006011574A1 (de)	2006-03-10	2007-10-31	Grünenthal GmbH	Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
MY148217A (en) *	2006-12-21	2013-03-29	Hoffmann La Roche	Polymorphs of a mglur5 receptor antagonist
US8334287B2 (en) *	2009-07-17	2012-12-18	Hoffmann-La Roche Inc.	Imidazoles
US20120040008A1 (en) *	2010-08-11	2012-02-16	Ashish Chatterji	Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) *	2010-08-11	2012-02-16	Ashish Chatterji	Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20140228398A1 (en)	2011-03-18	2014-08-14	Novartis Ag	COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
EP2909180B1 (de) *	2012-10-18	2016-10-05	F. Hoffmann-La Roche AG	Ethynylderivate als modulatoren der mglur5-rezeptoraktivität
EA026941B1 (ru) *	2012-10-18	2017-06-30	Ф. Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ АКТИВНОСТИ РЕЦЕПТОРА mGluR5
MX2018011765A (es) *	2016-03-30	2019-05-20	Sinntaxis AB	Moduladores alostéricos negativos del receptor 5 metabotrópico de glutamato (mglur5) para su uso en el tratamiento de daños cerebrales maduros.
IL298709A (en) *	2020-06-05	2023-02-01	Noema Pharma Ag	Methods for treating multiple sclerosis complex
CN115989024A (zh)	2020-07-30	2023-04-18	诺埃玛制药公司	治疗三叉神经痛的方法
CN120641098A (zh)	2023-02-02	2025-09-12	诺埃玛制药公司	Dravet综合征的治疗方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0079312A3 (de) *	1981-11-11	1984-04-25	Ciba-Geigy Ag	Heterocyclische Acetylenverbindungen
TW544448B (en) *	1997-07-11	2003-08-01	Novartis Ag	Pyridine derivatives
WO2001016121A1 (en) *	1999-08-31	2001-03-08	Merck & Co., Inc.	Heterocyclic compounds and methods of use thereof
JP5154728B2 (ja) *	2000-07-24	2013-02-27	クレニツキー・ファーマシューティカルズ，インコーポレイテッド	神経栄養活性を有する置換５−アルキニルピリミジン
ATE288898T1 (de) *	2000-12-04	2005-02-15	Hoffmann La Roche	Phenylethenyl- oder phenylethinylderivate als glutamatrezeptorantagonisten
EP1458385A4 (de) *	2001-12-19	2005-12-21	Merck & Co Inc	Heteroaryl-substituierte imidazol-modulatoren des metabotropen glutamat-rezeptors-5
EP1556142A4 (de) *	2002-10-24	2006-11-08	Merck & Co Inc	Alkyn-derivate als tracer für die metabotrope glutamat-rezeptor-bindung
TWI292318B (en) *	2003-03-10	2008-01-11	Hoffmann La Roche	Imidazol-4-yl-ethynyl-pyridine derivatives
UA80888C2 (en) *	2003-06-05	2007-11-12	Hoffmann La Roche	Imidazole derivatives as glutmate receptor antagonists
US7091222B2 (en) *	2003-07-03	2006-08-15	Hoffmann-La Roche Inc.	Imidazole derivatives

2004
- 2004-01-06 UA UAA200512695A patent/UA80888C2/uk unknown
- 2004-06-01 CN CNB2004800156669A patent/CN100408572C/zh not_active Expired - Lifetime
- 2004-06-01 CA CA2527315A patent/CA2527315C/en not_active Expired - Lifetime
- 2004-06-01 RS YU20050892A patent/RS53183B/sr unknown
- 2004-06-01 NZ NZ543637A patent/NZ543637A/en not_active IP Right Cessation
- 2004-06-01 WO PCT/EP2004/005881 patent/WO2004108701A1/en not_active Ceased
- 2004-06-01 PT PT04739484T patent/PT1636206E/pt unknown
- 2004-06-01 HR HR20070529T patent/HRP20070529T3/xx unknown
- 2004-06-01 JP JP2006508238A patent/JP4401384B2/ja not_active Expired - Lifetime
- 2004-06-01 AT AT04739484T patent/ATE377008T1/de active
- 2004-06-01 PL PL04739484T patent/PL1636206T3/pl unknown
- 2004-06-01 EP EP04739484A patent/EP1636206B1/de not_active Expired - Lifetime
- 2004-06-01 AU AU2004245208A patent/AU2004245208B2/en not_active Expired
- 2004-06-01 DK DK04739484T patent/DK1636206T3/da active
- 2004-06-01 SI SI200430525T patent/SI1636206T1/sl unknown
- 2004-06-01 KR KR1020057023137A patent/KR100778948B1/ko not_active Expired - Lifetime
- 2004-06-01 BR BRPI0411095A patent/BRPI0411095B8/pt not_active IP Right Cessation
- 2004-06-01 EA EA200501887A patent/EA010577B1/ru not_active IP Right Cessation
- 2004-06-01 DE DE602004009796T patent/DE602004009796T2/de not_active Expired - Lifetime
- 2004-06-01 MX MXPA05013149A patent/MXPA05013149A/es active IP Right Grant
- 2004-06-01 ES ES04739484T patent/ES2294504T3/es not_active Expired - Lifetime
- 2004-06-02 CL CL200401347A patent/CL2004001347A1/es unknown
- 2004-06-02 PE PE2004000558A patent/PE20050162A1/es active IP Right Grant
- 2004-06-02 TW TW093115811A patent/TWI338007B/zh not_active IP Right Cessation
- 2004-06-02 US US10/858,969 patent/US7332510B2/en not_active Expired - Lifetime
- 2004-06-02 PA PA20048604101A patent/PA8604101A1/es unknown
- 2004-06-03 AR ARP040101908A patent/AR044478A1/es active IP Right Grant
- 2004-06-03 MY MYPI20042150A patent/MY137272A/en unknown
- 2004-06-03 HN HN2004000208A patent/HN2004000208A/es unknown
- 2004-06-03 GT GT200400117A patent/GT200400117A/es unknown
2005
- 2005-05-27 MY MYPI20052424A patent/MY143353A/en unknown
- 2005-11-13 IL IL171930A patent/IL171930A/en active IP Right Grant
- 2005-11-14 CR CR8094A patent/CR8094A/es unknown
- 2005-11-18 NO NO20055465A patent/NO332143B1/no unknown
- 2005-12-01 TN TNP2005000309A patent/TNSN05309A1/fr unknown
- 2005-12-02 EC EC2005006202A patent/ECSP056202A/es unknown
- 2005-12-02 ZA ZA200509807A patent/ZA200509807B/en unknown
- 2005-12-09 MA MA28648A patent/MA27881A1/fr unknown
2006
- 2006-11-21 ZA ZA200609681A patent/ZA200609681B/xx unknown
- 2006-11-27 TN TNP2006000391A patent/TNSN06391A1/fr unknown
2007
- 2007-10-31 US US11/930,258 patent/US8481548B2/en active Active
- 2007-12-13 US US11/955,421 patent/US7973165B2/en not_active Expired - Lifetime
2008
- 2008-01-11 CY CY20081100047T patent/CY1107856T1/el unknown

Also Published As

Publication number	Publication date
US20040248888A1 (en)	2004-12-09
CA2527315C (en)	2010-08-10
CL2004001347A1 (es)	2005-05-06
US7332510B2 (en)	2008-02-19
PT1636206E (pt)	2008-01-28
IL171930A0 (en)	2006-04-10
ZA200509807B (en)	2006-12-27
TW200509920A (en)	2005-03-16
EA010577B1 (ru)	2008-10-30
KR100778948B1 (ko)	2007-11-28
MXPA05013149A (es)	2006-03-17
MY143353A (en)	2011-04-29
CN100408572C (zh)	2008-08-06
MA27881A1 (fr)	2006-05-02
ECSP056202A (es)	2006-04-19
EP1636206B1 (de)	2007-10-31
SI1636206T1 (sl)	2008-02-29
HRP20070529T3 (hr)	2008-05-31
HN2004000208A (es)	2009-02-03
ES2294504T3 (es)	2008-04-01
UA80888C2 (en)	2007-11-12
WO2004108701A1 (en)	2004-12-16
DE602004009796D1 (de)	2007-12-13
TNSN05309A1 (fr)	2007-07-10
BRPI0411095B8 (pt)	2021-05-25
HK1093070A1 (zh)	2007-02-23
US20080119489A1 (en)	2008-05-22
RS20050892A (sr)	2007-12-31
CR8094A (es)	2006-05-30
NO20055465L (no)	2005-11-18
CA2527315A1 (en)	2004-12-16
US7973165B2 (en)	2011-07-05
JP2006526588A (ja)	2006-11-24
IL171930A (en)	2010-12-30
AU2004245208B2 (en)	2007-04-26
KR20060057537A (ko)	2006-05-26
US20080103306A1 (en)	2008-05-01
PE20050162A1 (es)	2005-03-22
TNSN06391A1 (fr)	2008-02-22
PL1636206T3 (pl)	2008-04-30
EA200501887A1 (ru)	2006-10-27
DK1636206T3 (da)	2008-02-11
JP4401384B2 (ja)	2010-01-20
EP1636206A1 (de)	2006-03-22
MY137272A (en)	2009-01-30
RS53183B (sr)	2014-06-30
BRPI0411095B1 (pt)	2018-04-03
DE602004009796T2 (de)	2008-08-28
GT200400117A (es)	2005-02-07
TWI338007B (en)	2011-03-01
US8481548B2 (en)	2013-07-09
AU2004245208A1 (en)	2004-12-16
CN1802367A (zh)	2006-07-12
NZ543637A (en)	2008-04-30
ZA200609681B (en)	2008-06-25
CY1107856T1 (el)	2013-06-19
AR044478A1 (es)	2005-09-14
PA8604101A1 (es)	2004-12-16
NO332143B1 (no)	2012-07-02
BRPI0411095A (pt)	2006-07-18

Legal Events

Date

Code

Title

Description

2008-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1636206

Country of ref document: EP

Publication	Publication Date	Title
ATE384053T1 (de)	2008-02-15	Triazolderivate als tachykininrezeptor- antagonisten
CY2017032I1 (el)	2018-02-14	Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2
ATE413400T1 (de)	2008-11-15	Cgrp-rezeptorantagonisten
ATE394391T1 (de)	2008-05-15	Indolderivate als histaminrezeptorantagonisten
DK1951660T3 (da)	2014-01-27	Histamin-3-receptorantagonister
ATE461191T1 (de)	2010-04-15	N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
ATE344798T1 (de)	2006-11-15	Als histamin-h3-antagonisten geeignete indolderivate
DE602006015607D1 (de)	2010-09-02	Thiazol-4-carboxamid-derivate als mglur5-antagonisten
ATE555111T1 (de)	2012-05-15	Chinuclidinol-derivate als muscarinrezeptor- antagonisten
DE60316411D1 (de)	2007-10-31	Thiazolderivate als npy-rezeptorantagonisten
DK1711465T3 (da)	2008-03-31	Hydroisoindolin-tachykinikreceptorantagonister
ATE518834T1 (de)	2011-08-15	2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten
DE602004004278D1 (de)	2007-02-22	4-cycloalkylaminopyrazolopyrimidin als nmda/nr2b-antagonisten
ATE421511T1 (de)	2009-02-15	Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors
DE602004009796D1 (de)	2007-12-13	Imidazolderivate als glutamatrezeptorantagonisten
ATE403651T1 (de)	2008-08-15	3-fluoro-piperidine als nmda/nr2b antagonisten
DE602005009355D1 (de)	2008-10-09	Gehinderte himbacinanaloga als thrombinrezeptorantagonisten
NL2000241A1 (nl)	2007-03-22	Carboxamidederivaten als muscarine-receptorantagonisten.
ATE414078T1 (de)	2008-11-15	Indol-3-ylcarbonylpiperidinbenzimidazolderivate als v1a-rezeptorantagonisten
ATE495168T1 (de)	2011-01-15	Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten
ATE427945T1 (de)	2009-04-15	Imidazolderivate
ATE504300T1 (de)	2011-04-15	Harnstoffderivate als il-8-rezeptorantagonisten
ATE528291T1 (de)	2011-10-15	Cyclopropylderivate als nk3 rezeptor-antagonisten
ATE488519T1 (de)	2010-12-15	Indol-3-ylcarbonylazaspiroderivate als vasopressinrezeptorantagonisten
ATE425161T1 (de)	2009-03-15	Mercaptoimidazole als ccr2-rezeptorantagonisten